ARTICLE | Company News
Parsabiv sales and marketing update
March 1, 2017 10:51 PM UTC
Ono launched Parsabiv etelcalcetide in Japan to treat secondary hyperparathyroidism in patients on hemodialysis. The National Health Insurance (NHI) price of a 5 mg vial of Parsabiv, the starting dose...
BCIQ Company Profiles
BCIQ Target Profiles